MAPK3 and breast carcinoma: Similarly, active pERK1/2 was highly stained in ~38% of our recruited breast cancer specimens and positively correlated with higher expression of ERK1 (~30%) and ERK2 (~39%), in agreement with the trend seen in mRNA levels [21].